| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| WeWork Inc. | Director | Common Stock | 53.4K | $126K | $2.36 | Aug 10, 2022 | Direct |
| Pear Therapeutics, Inc. | Director | Class A Common Stock | 61.9K | Feb 15, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PEARQ | Pear Therapeutics, Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |
| WE | WeWork Inc. | Feb 2, 2023 | 0 | $0 | 4 | Feb 7, 2023 | Director |
| WE | WeWork Inc. | Aug 10, 2022 | 1 | $0 | 4 | Aug 12, 2022 | Director |
| PEARQ | Pear Therapeutics, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| WE | WeWork Inc. | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
| WE | WeWork Inc. | Dec 28, 2021 | 1 | $0 | 4 | Dec 30, 2021 | Director |
| ATEK | Athena Technology Acquisition Corp. II | Dec 9, 2021 | 0 | $0 | 3 | Dec 9, 2021 | President |
| PEARQ | Pear Therapeutics, Inc. | Dec 8, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Director |
| PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 1 | $0 | 4 | Dec 7, 2021 | Director |
| PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 0 | $0 | 3 | Dec 7, 2021 | Director |
| WE | WeWork Inc. | Oct 20, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Director |